GlassScriptPhysician profile
Ruchi Bansal
NPI 1134425754
$3,067.42
in general payments reported to CMS, 2019-2025
23 companies · $472 in 2025
The $472 reported for 2025 was more than what a typical Sleep Medicine (Internal Medicine) provider received nationally (typical 2025 total: $447).
See the full distribution for Sleep Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $400 · 2020: $55.23 · 2021: $351 · 2022: $788 · 2023: $379 · 2024: $621 · 2025: $472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,472.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $825.02 | 2019-2024 | Trelegy Ellipta, Nucala, Arexvy |
| Inspire Medical Systems, INC. | $329.72 | 2024-2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $329.71 | 2019-2025 | Airsupra, Symbicort |
| Boehringer Ingelheim Pharmaceuticals, INC. | $327.88 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Harmony Biosciences LLC | $236.30 | 2022-2024 | Wakix |
| Jazz Pharmaceuticals INC. | $199.69 | 2021-2023 | |
| Silk Road Medical, INC. | $135.38 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Lilly USA, LLC | $119.49 | 2025 | Zepbound, Mounjaro |
| Medtronic, INC. | $97.56 | 2025 | Closurefast |
| Mylan Specialty L.P. | $75.90 | 2022-2024 | Yupelri |
| Bayer Healthcare Pharmaceuticals INC. | $64.38 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $53.47 | 2021-2024 | Winrevair |
| Philips North America LLC | $49.95 | 2019 | |
| Pulmonx Corporation | $37.63 | 2023-2024 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Apria Healthcare LLC | $31.52 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Respiratory, INC | $29.71 | 2019 | |
| Grifols USA, LLC | $27.27 | 2022 | |
| Genzyme Corporation | $22.81 | 2023 | |
| Electromed, INC. | $20.95 | 2024 | Smartvest |
| Vanda Pharmaceuticals INC. | $17.48 | 2021 | |
| Sunovion Pharmaceuticals INC. | $12.08 | 2019 | |
| Phadia US INC. | $11.87 | 2021 | |
| Janssen Pharmaceuticals, INC | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruchi Bansal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.